July 20/Oak Brook, Ill./PRNewswire -- PureCircle announced that FDA has issued a No Objection letter for the use of PureCircle's SG95 product as a food and beverage ingredient in the United States. This will enable PureCircle to offer a wider and more flexible array of stevia solutions to manufacturers in the U.S. market, the company claims.

PureCircle's high purity SG95 product includes two new steviol glycosides, Rebaudioside D and Rebaudioside F, both of which are receiving GRAS No Objection for the first time. The product is suitable for applications formulated with both sugar and SG95, to achieve a lower-cost solution to partial sugar and calorie reduction. With GRAS affirmation, PureCircle is prepared for immediate commercialization of SG95.

Magomet Malsagov, CEO and managing director of PureCircle, stated, "The launch of SG95 is a very exciting development for PureCircle in the U.S. with considerable future potential in global markets. Expanded use of sweet glycosides from the stevia plant provides both formulation and economic benefits to our customers. Our Reb A 97 continues to play a major role in our portfolio, particularly as our investments yield continued efficiencies that will be shared with our customers. Now, SG95 will provide an additional compelling product today in many applications. We are proud to continue to be at the forefront of innovation to help mainstream a better sweet choice for consumers. "

From the August 2, 2010, Prepared Foods E-dition